We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ARIPIPRAZOLE SANDOZ DEPOT (Sandoz Pty Ltd)
Product name
ARIPIPRAZOLE SANDOZ DEPOT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (255 working days)
Active ingredients
aripiprazole, aripiprazole monohydrate
Registration type
New generic medicine
Indication
For the acute and maintenance treatment of schizophrenia in adults.
For maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar I disorder in adult patients as monotherapy.